Press release
Virology Market, 2015-2025 by Segmentation Based on Product, Application and Region
Future Market Insights has announced the addition of the “Virology Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.Virology is the part of micro biology or pathology deals with viruses and virus like agents, disease producing properties, cultivation and genetics. Viruses are responsible for various disease that must be controlled or developed. However, viruses also have certain beneficial properties that can be exploited for useful purposes such as gene therapy or vaccinology. Viruses are an obligate intracellular molecular parasites and they do not reproduce by binary fission. In general, viruses contain only one type of nucleic acid (either DNA or RNA) that carries the information necessary for viral replication. Viral test helps to diagnoses infection causing viruses. Viruses can be diagnosed by different procedures such as cell culture method, specific antibodies detection, antigen detection, virus nucleic acid detection, gene sequencing and hemagglutination assays. Viral infection can be controlled by immunoprophylaxis, antiviral chemotherapy and interferons.
Virology Market: Drivers & Restraints
Global virology market is projected to grow due to high prevalence of infectious diseases particularly, flu, hepatitis, sexually transmitted diseases, etc. Major drivers for global virology market are increasing strong research and development activities such as novel point of care diagnostic tests and treatments, increase in healthcare expenditure, and increase in the public awareness. Additionally, safety and quality of viral controlling therapy may possibly be a challenge for the growth of the global virology market. Moreover, numerous public awareness programs for STD’s, Ebola, Flu disease are targeted to increase awareness levels are also being accompanied. Some major patent expiries are expected by the end of 2017 for Combivir, Sustiva, Tamiflu, Tenofovir, Telbivudine, and Relenza. The patent expiries of these blockbuster drugs will trigger generic competition in the virology market, making it more competitive. And also late stage pipeline drugs such as Elvitegravir, Inavir, Rapiacta, Rilpivirine and Vicriviroc are estimated to enter the market, which will positively impact the market. However, serious side effects and resistance towards antiviral drugs and stringent regulatory approvals for new treatment options with better levels of efficacy and safety are obstructing the global virology market.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1150
Virology Market: Segmentation
The global virology drugs market is classified on the basis of product type, application, end use and region.
Based on product type, the global virology market is segmented into the following:
Diagnosing Test
DNA Viruses
RNA Viruses
Prions Diagnostic Test
Other Viral Tests
Viral Infection Controlling Methods
Immunoprophylaxis
Active Prophylaxis (Vaccines)
Passive Prophylaxis
Antiviral Chemotherapy
Virucidal Agents
Antiviral Agents
Immunomodulators
Interferons
Cytokines
Based on application type, the global virology market is segmented into the following:
Skin and Soft Tissue Infections
Respiratory Tract Infections
GI Tract Infections
Urinary Tract Infections
Eye Infections
CNS Infections
Sexually Transmitted Diseases
Perinatal Infections
Based on end user type, the global virology market is segmented into the following:
Hospitals
Clinics
Laboratories
Diagnostic Centers
Blood Banks
Pharmacies
Full Report Analysis@ http://www.futuremarketinsights.com/reports/virology-market
Virology Market: Overview
Global virology market growth is fast in North American region and is estimated to project remarkable CAGR growth throughout forecast period due to technological development of rapid and portable diagnostic tests. The second largest and fastest growing global virology market is Europe owing to development of healthcare infrastructure, accessibility and affordability of diagnostic tests for viral infectious diseases. The United States is the biggest market for antiviral drugs, followed by the U.K. and Japan. However, Asia-Pacific and African regions of the world are considered as the most promising markets in the forecast period. In Asia Pacific virology market, remaining to the presence of high unmet demand in India and China, is anticipated to grow at a relatively faster rate throughout the forecast period. On the basis of viral controlling methods immunoprophylaxis therapy and antiviral drugs are fastest-growing market segments in the estimated forecast period. On the basis of application, the sexually transmitted diseases, urinary tract infections, and respiratory tract infections are dominating as compared to other application types in global virology market. On the basis of diagnosis tests Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), human papillomavirus (HPV), and other tests (Influenza, Ebola, and Dengue included) are assessed the foremost market share in the global virology market. By end use, hospitals and laboratories segments held 50% share in the global virology market and the trend is forecast to continue through 2025.
Virology Market: Key Players
The global virology market key players are GlaxoSmithKline, plc. Abbott Laboratories, AstraZeneca AB, Boehringer Ingelheim Corporation, Novartis International AG, Merck and Co. Inc., Johnson & Johnson, Roche, Siemens, etc.
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
Future Market Insights
616 Corporate Way,
Suite 2-9018,
Valley Cottage,
New York 10989,
United States
Tel: +1-347-918-3531
Fax: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Virology Market, 2015-2025 by Segmentation Based on Product, Application and Region here
News-ID: 332495 • Views: …
More Releases from FMI

Cow Colostrum Market to grow at 6.3% CAGR through 2031
According to a recent market study by Future Market Insights (FMI), the global cow colostrum market is projected to display a CAGR of over 6% during the forecast period from 2021 – 3031. According to a field survey conducted by ColoPlus AB, the use of colostrum in medical nutritional food boosts the immune system of children diagnosed with acquired immune deficiency syndrome (HIV/AIDS), as well as lowers the risk of…

Quillaja Extract Market likely to surge at a vigorous 10% CAGR during the assess …
Future Market Insights’ (FMI’s) study has projected the quillaia extract market to reach a valuation of 11.9 Mn in 2021. Rising focus on including natural ingredients in pet food will create opportunities for growth between 2021 and 2031.
Demand for nutritional and plant-based ingredients in pet food from the pet owners is pushing the production adoption of quillaia extract, widening growth opportunities for the manufacturers. Increasing awareness about the pet’s food…

Postnatal Health Supplements Market likely to surge at a vigorous 7% CAGR during …
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers details about key factors driving demand for postnatal health supplements. The report tracks the global sales of postnatal health supplements in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the dietary supplements industry in general, and postnatal health supplements in particular.
The global postnatal health supplements market is forecast to expand at…

Citrus Seeds Market to grow at 6.3% CAGR through 2021- 2031
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving the demand for citrus seeds. The report tracks the global sales of citrus seeds in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the food and beverage industry in general, and citrus seeds in particular.
Request a free report sample to obtain authentic analysis and comprehensive market…
More Releases for Virology
Virology Market: Technological Innovations & Market Insights till 2030
The study of Virology Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. Also this…
Virology Market Opportunities, Demand and Forecasts, 2015-2025
Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Early in 2016, the WHO officially…
11th International Virology and Infectious Diseases Congress
Conference Series invites all the participants from all over the world to attend Virology Congress Conference which is to be held during July 27th -28th, 2018 Vancouver, Canada which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
11th International Virology and Infectious Diseases Congress is a global platform to discuss and learn about Viral infections, Molecular biology, Epidemiology, Monoclonal antibodies, Virology Research, Viro therapy, Pediatric Infectious Diseases, Urinary…
11th International Virology and Infectious Diseases Congress
Conference Series invites all the participants from all over the world to attend Virology Congress Conference which is to be held during July 27th -28th, 2018 Vancouver, Canada which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Conference Series invites all the participants from all over the world to attend Virology Congress Conference which is to be held during July 27th -28th, 2018 Vancouver, Canada which includes prompt keynote…
A recent study offers insight about the Virology Market
Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Early in 2016, the WHO officially…
Good Growth Opportunities in Global Virology Market Till 2025
Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Early in 2016, the WHO officially…